MedTrace Logo

Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis

NCT00368719 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2015-04-07

No results posted yet for this study

Summary

To assess the long-term safety of tacrolimus ointment

Conditions

Interventions

DRUG

Tacrolimus

Participants will be followed for 10 years to study the effects of Tacrolimus.

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Fu-Tong Liu, M.D., Ph.D. · Physician with UC Davis Department of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Completion
2016-07-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00368719 on ClinicalTrials.gov